144 related articles for article (PubMed ID: 36827954)
1. Lupus anticoagulant laboratory diagnosis by applying the 2020 ISTH-SSC guidelines.
Talon L; Fourneyron V; Senectaire S; Tardieu M; Tillier M; Trapani A; Trayaud A; Vaissade A; Sapin AF; Lebreton A; Sinegre T
Thromb Res; 2023 Apr; 224():38-45. PubMed ID: 36827954
[TBL] [Abstract][Full Text] [Related]
2. Variability of cut-off values for the detection of lupus anticoagulants: results of an international multicenter multiplatform study.
Tripodi A; Chantarangkul V; Cini M; Devreese K; Dlott JS; Giacomello R; Gray E; Legnani C; Martinuzzo ME; Pradella P; Siegemund A; Subramanian S; Suchon P; Testa S
J Thromb Haemost; 2017 Jun; 15(6):1180-1190. PubMed ID: 28316135
[TBL] [Abstract][Full Text] [Related]
3. Variability among commercial batches of normal pooled plasma in lupus anticoagulant testing.
Cabo J; Morimont L; Baudar J; Guldenpfennig M; Jacqmin H; Soleimani R; Lecompte T; Douxfils J; Mullier F
Int J Lab Hematol; 2023 Feb; 45(1):126-136. PubMed ID: 36222181
[TBL] [Abstract][Full Text] [Related]
4. Guidance from the Scientific and Standardization Committee for lupus anticoagulant/antiphospholipid antibodies of the International Society on Thrombosis and Haemostasis: Update of the guidelines for lupus anticoagulant detection and interpretation.
Devreese KMJ; de Groot PG; de Laat B; Erkan D; Favaloro EJ; Mackie I; Martinuzzo M; Ortel TL; Pengo V; Rand JH; Tripodi A; Wahl D; Cohen H
J Thromb Haemost; 2020 Nov; 18(11):2828-2839. PubMed ID: 33462974
[TBL] [Abstract][Full Text] [Related]
5. Applying index of circulating anticoagulant to mixing tests with lupus anticoagulant screen and confirm reagents can distinguish with high specificity between lupus anticoagulants and direct factor Xa inhibitors.
Kumano O; Amiral J; Dunois C; Peyrafitte M; Moore GW
Int J Lab Hematol; 2021 Aug; 43(4):771-778. PubMed ID: 33974363
[TBL] [Abstract][Full Text] [Related]
6. Mixing test specific cut-off is more sensitive at detecting lupus anticoagulants than index of circulating anticoagulant.
Moore GW; Culhane AP; Daw CR; Noronha CP; Kumano O
Thromb Res; 2016 Mar; 139():98-101. PubMed ID: 26916303
[TBL] [Abstract][Full Text] [Related]
7. Dilute Russell's viper venom and activated partial thromboplastin time in lupus anticoagulant diagnosis: is mixing essential?
Chandrashekar V
Blood Coagul Fibrinolysis; 2016 Jun; 27(4):408-11. PubMed ID: 26626041
[TBL] [Abstract][Full Text] [Related]
8. Validation of mixing test-specific cut-off in lupus anticoagulant mixing test interpretation for multiple reagents.
Kumano O; Moore GW
Thromb Res; 2023 Nov; 231():39-43. PubMed ID: 37801773
[No Abstract] [Full Text] [Related]
9. Coagulation tests and anti-phospholipid antibodies in patients positive for lupus anticoagulant.
Sakakura M; Wada H; Watanabe R; Mamamuro M; Okugawa Y; Nakasaki T; Nakase T; Wakita Y; Minamikawa K; Mori Y; Nshikawa M; Shiku H
Clin Appl Thromb Hemost; 2000 Jul; 6(3):144-50. PubMed ID: 10898274
[TBL] [Abstract][Full Text] [Related]
10. Mixing studies in lupus anticoagulant testing are required at least in some type of samples.
Devreese KM; de Laat B
J Thromb Haemost; 2015 Aug; 13(8):1475-8. PubMed ID: 26017873
[TBL] [Abstract][Full Text] [Related]
11. Differences in lupus anticoagulant final conclusion through clotting time or Rosner index for mixing test interpretation.
Depreter B; Devreese KM
Clin Chem Lab Med; 2016 Sep; 54(9):1511-6. PubMed ID: 26894579
[TBL] [Abstract][Full Text] [Related]
12. New guidelines for lupus anticoagulant: sensitivity and specificity of cut-off values calculated with plasmas from healthy controls in mixing and confirmatory tests.
Martinuzzo ME; Cerrato GS; Varela ML; Adamczuk YP; Forastiero RR
Int J Lab Hematol; 2012 Apr; 34(2):208-13. PubMed ID: 22032515
[TBL] [Abstract][Full Text] [Related]
13. Lupus Anticoagulant Testing: Dilute Prothrombin Time (dPT).
Moore GW
Methods Mol Biol; 2023; 2663():275-288. PubMed ID: 37204717
[TBL] [Abstract][Full Text] [Related]
14. The dilution effect of equal volume mixing studies compromises confirmation of inhibition by lupus anticoagulants even when mixture specific reference ranges are applied.
Moore GW; Savidge GF
Thromb Res; 2006; 118(4):523-8. PubMed ID: 16263154
[TBL] [Abstract][Full Text] [Related]
15. International multicenter, multiplatform study to validate Taipan snake venom time as a lupus anticoagulant screening test with ecarin time as the confirmatory test: Communication from the ISTH SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies.
Moore GW; Jones PO; Platton S; Hussain N; White D; Thomas W; Rigano J; Pouplard C; Gray E; Devreese KMJ
J Thromb Haemost; 2021 Dec; 19(12):3177-3192. PubMed ID: 34192404
[TBL] [Abstract][Full Text] [Related]
16. Clinical usefulness of the dilute Russell viper venom time test for patients taking warfarin.
Kanouchi K; Narimatsu H; Ohnuma O; Morikane K; Fukao A
Int J Hematol; 2017 Aug; 106(2):206-211. PubMed ID: 28390037
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of the mixing test in laboratory diagnoses of lupus anticoagulant: the fate of the mixing test in integrated lupus anticoagulant test systems.
Hong SK; Hwang SM; Kim JE; Kim HK
Blood Coagul Fibrinolysis; 2012 Dec; 23(8):739-44. PubMed ID: 22964767
[TBL] [Abstract][Full Text] [Related]
18. The activated seven lupus anticoagulant assay detects clinically significant antibodies.
Moore GW; Rangarajan S; Savidge GF
Clin Appl Thromb Hemost; 2008 Jul; 14(3):332-7. PubMed ID: 17895508
[TBL] [Abstract][Full Text] [Related]
19. Testing for Lupus Anticoagulants.
Moore GW
Semin Thromb Hemost; 2022 Sep; 48(6):643-660. PubMed ID: 35649428
[TBL] [Abstract][Full Text] [Related]
20. Commonalities and contrasts in recent guidelines for lupus anticoagulant detection.
Moore GW
Int J Lab Hematol; 2014 Jun; 36(3):364-73. PubMed ID: 24750683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
